177 related articles for article (PubMed ID: 36470074)
1. The transcriptional activity of progestins used in contraception and menopausal hormone therapy via progesterone receptor A is dependent on the density of the receptor.
Cartwright M; Toit RL; Africander D
Biochem Biophys Res Commun; 2023 Jan; 639():70-76. PubMed ID: 36470074
[TBL] [Abstract][Full Text] [Related]
2. Progesterone receptor isoform ratios influence the transcriptional activity of progestins via the progesterone receptor.
Cartwright M; Louw-du Toit R; Jackson H; Janse van Vuuren M; Africander D
J Steroid Biochem Mol Biol; 2023 Sep; 232():106348. PubMed ID: 37315868
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of an estrogen receptor-regulated gene by first generation progestins requires both the progesterone receptor and estrogen receptor alpha.
Perkins MS; Louw-du Toit R; Jackson H; Simons M; Africander D
Front Endocrinol (Lausanne); 2022; 13():959396. PubMed ID: 36187129
[TBL] [Abstract][Full Text] [Related]
4. A direct comparison of the transcriptional activities of progestins used in contraception and menopausal hormone therapy via the mineralocorticoid receptor.
Louw-du Toit R; Hapgood JP; Africander D
Biochem Biophys Res Commun; 2020 May; 526(2):466-471. PubMed ID: 32234237
[TBL] [Abstract][Full Text] [Related]
5. Progestins and breast cancer hallmarks: The role of the ERK1/2 and JNK pathways in estrogen receptor positive breast cancer cells.
Louw-du Toit R; Simons M; Africander D
J Steroid Biochem Mol Biol; 2024 Mar; 237():106440. PubMed ID: 38048919
[TBL] [Abstract][Full Text] [Related]
6. Comparing the androgenic and estrogenic properties of progestins used in contraception and hormone therapy.
Louw-du Toit R; Perkins MS; Hapgood JP; Africander D
Biochem Biophys Res Commun; 2017 Sep; 491(1):140-146. PubMed ID: 28711501
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of progestins used in hormonal contraception and progesterone via the progesterone receptor.
Enfield K; Cartwright M; Toit RL; Avenant C; Africander D; Hapgood JP
Biochem Biophys Res Commun; 2020 Dec; 533(4):879-885. PubMed ID: 33008590
[TBL] [Abstract][Full Text] [Related]
8. Transactivation of progestin- and estrogen-responsive promoters by 19-nor progestins in African Green Monkey Kidney CV1 cells.
Pasapera AM; Gutiérrez-Sagal R; García-Becerra R; Ulloa-Aguirre A; Savouret JF
Endocrine; 2001 Dec; 16(3):217-25. PubMed ID: 11954666
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of gene regulation by seven clinically relevant progestins suggests a highly similar mechanism of action through progesterone receptors in T47D breast cancer cells.
Bray JD; Jelinsky S; Ghatge R; Bray JA; Tunkey C; Saraf K; Jacobsen BM; Richer JK; Brown EL; Winneker RC; Horwitz KB; Lyttle CR
J Steroid Biochem Mol Biol; 2005 Dec; 97(4):328-41. PubMed ID: 16157482
[TBL] [Abstract][Full Text] [Related]
10. An amino-terminal truncated progesterone receptor isoform, PRc, enhances progestin-induced transcriptional activity.
Wei LL; Hawkins P; Baker C; Norris B; Sheridan PL; Quinn PG
Mol Endocrinol; 1996 Nov; 10(11):1379-87. PubMed ID: 8923464
[TBL] [Abstract][Full Text] [Related]
11. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential.
Fuhrmann U; Krattenmacher R; Slater EP; Fritzemeier KH
Contraception; 1996 Oct; 54(4):243-51. PubMed ID: 8922878
[TBL] [Abstract][Full Text] [Related]
12. Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors.
Salazar M; Lerma-Ortiz A; Hooks GM; Ashley AK; Ashley RL
Gene; 2016 Oct; 591(1):6-13. PubMed ID: 27349565
[TBL] [Abstract][Full Text] [Related]
13. Classification and pharmacology of progestins.
Schindler AE; Campagnoli C; Druckmann R; Huber J; Pasqualini JR; Schweppe KW; Thijssen JH
Maturitas; 2003 Dec; 46 Suppl 1():S7-S16. PubMed ID: 14670641
[TBL] [Abstract][Full Text] [Related]
14. Met909 plays a key role in the activation of the progesterone receptor and also in the high potency of 13-ethyl progestins.
Petit-Topin I; Turque N; Fagart J; Fay M; Ulmann A; Gainer E; Rafestin-Oblin ME
Mol Pharmacol; 2009 Jun; 75(6):1317-24. PubMed ID: 19289570
[TBL] [Abstract][Full Text] [Related]
15. Differential metabolism of clinically-relevant progestogens in cell lines and tissue: Implications for biological mechanisms.
Skosana SB; Woodland JG; Cartwright M; Enfield K; Komane M; Louw-du Toit R; van der Spuy Z; Avenant C; Africander D; Storbeck KH; Hapgood JP
J Steroid Biochem Mol Biol; 2019 May; 189():145-153. PubMed ID: 30822501
[TBL] [Abstract][Full Text] [Related]
16. In vitro characterization of trimegestone: a new potent and selective progestin.
Zhang Z; Lundeen SG; Zhu Y; Carver JM; Winneker RC
Steroids; 2000; 65(10-11):637-43. PubMed ID: 11108870
[TBL] [Abstract][Full Text] [Related]
17. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
[TBL] [Abstract][Full Text] [Related]
18. Rat uterine complement C3 expression as a model for progesterone receptor modulators: characterization of the new progestin trimegestone.
Lundeen SG; Zhang Z; Zhu Y; Carver JM; Winneker RC
J Steroid Biochem Mol Biol; 2001 Aug; 78(2):137-43. PubMed ID: 11566438
[TBL] [Abstract][Full Text] [Related]
19. Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells.
Ruan X; Neubauer H; Yang Y; Schneck H; Schultz S; Fehm T; Cahill MA; Seeger H; Mueck AO
Climacteric; 2012 Oct; 15(5):467-72. PubMed ID: 22335423
[TBL] [Abstract][Full Text] [Related]
20. Progestogens exhibit progestogen-, promoter- and isoform-specific effects via the progesterone receptor.
Enfield K; Avenant C; Hapgood JP
Steroids; 2022 Nov; 187():109094. PubMed ID: 35905833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
